Navigation Links Reports First Quarter 2008 Results

Including an 18% Increase in Revenues

DALLAS, May 6 /PRNewswire-FirstCall/ -- inc. (OTC Bulletin Board: CLAI), a leading provider of Internet-based business-to-business solutions for the healthcare industry, today reported its results for the first quarter of fiscal 2008, which ended March 31, 2008.

For the quarter ended March 31, 2008, the Company reported revenues of $490,000, an 18% increase from the $415,000 reported for the first quarter of 2007.

Expenses overall, comprised of cost of revenues and operating expenses, increased 19% compared with the first quarter of 2007. Cost of revenues for the first quarter of 2008 was $392,000 compared to $301,000 in the first quarter of 2007, a 30% increase. Selling, general and administrative expenses of $201,000 were reported for the first quarter of 2008, representing a 2% increase from the $198,000 reported in the first quarter of 2007.

The Company reported a gross profit of $98,000 for the first quarter of 2008, compared with a $114,000 gross profit in the first quarter of 2007. This is the nineteenth consecutive quarter in which the Company has reported a gross profit.

The loss from operations for the first quarter of 2008 was $103,000, compared to a loss of $84,000 reported in the first quarter of 2007. The net loss for the first quarter of 2008 was $132,000, or $0.00 per share, compared to $107,000, or $0.00 per share, in the first quarter of 2007.

"While we are pleased with the 18% growth in sales, our loss from operations increased compared to last year. This primarily resulted from extra efforts that were expended to upgrade our ASP server operations, providing updated hardware and software and increased capacity. Our expectation is that going forward we will benefit from this upgrade as our efforts in sales growth continue to increase our sales, and expenses again return to more normal levels. In connection with these efforts, the Company hired a new Vice President of Sales to focus on the payer industry and a sales representative to improve our penetration of the provider community. The results of these efforts seem promising, based on initial results in the first month. In addition, we have substantially completed the integration of the operations of Acceptius into our operations, and as a result we have further options in our sales efforts for paper conversion of claims and medical claims repricing opportunities. We believe these things taken together, along with continued cost controls, will move us towards profitability by the end of this calendar year," commented Don Crosbie, chief executive officer of Claimsnet. inc. is a leading provider of Internet-based claim processing solutions for the healthcare payer industry, including distinctive, advanced ASP technology. Headquartered in Dallas, Texas, Claimsnet offers systems that are distinguished by ease of use, customer care, security and measurable cost advantages. More information on Claimsnet can be found at the Company's web site at

Forward-Looking Statements - With the exception of historical information, the matters discussed in this press release are forward looking statements that involve a number of risks and uncertainties. The actual future results of the Company could differ significantly from those statements. Factors that could cause or contribute to such differences include, but are not limited to, maintaining access to external sources of capital, regulatory actions, success of marketing strategies, actions of the Company's competitors, dependence on suppliers and distribution channels, continued use of the Internet, achieving the anticipated benefits of capital expenditures, and achieving anticipated expense reductions. Further information on the Company's risk factors is contained in the Company's quarterly, annual, and other periodic reports as filed with the Securities and Exchange Commission.

[Table to Follow]



(In thousands except per share data)


Quarter Ended

March 31,


2008 2007

---------- ----------

REVENUES $ 490 $ 415

COST OF REVENUES $ 392 $ 301

GROSS PROFIT $ 98 $ 114



INTEREST EXPENSE $ (29) $ (23)

NET LOSS $ (132) $ (107)


BASIC $(0.00) $(0.00)



BASIC AND DILUTED 26,879 26,043

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Reports Fiscal Year 2007 Results
2. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
3. Haemacure Reports Third Quarter 2007 Results
4. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
5. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
6. MDS Reports Third Quarter 2007 Results
7. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
8. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
9. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
10. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
11. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
Post Your Comments:
(Date:11/27/2015)... ... ... No.1 Herpes-only dating community in the world, revealed that over 50% of its members are ... people under the age of 50 – or 67% of the population - are infected ... HSV-1 infection . , "The data shocks us highly!" said Michelle Li, Co-Founder of ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping ... platform for mental health and wellness consultation, has collaborated with a leading web-based ... the knowledge gap experienced by parents and bring advice from parenting experts within ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., developer and ... of Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 product line. ... 5.10 up-to-date with a version of Asterisk that will receive not only security ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent ... and the need to integrate dose form selection in early phase drug development. ... membership organization supporting and bringing together the UK’s emerging life sciences companies, corporate ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... and wellness consultation, has collaborated with Women’s Web – an online resource ... on topics on mental and emotional well-being relationship, life balance, stress, professional ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... "Self Administration of High Viscosity Drugs" ... ) has announced the addition of the ... to their offering. --> Research and ... of the "Self Administration of High Viscosity ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the European Cell Surface Marker Testing ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/25/2015)... 25, 2015  Amgen (NASDAQ: AMGN ) today ... with the United States (U.S.) ... biosimilar candidate to Humira ® (adalimumab). Amgen believes ... to the FDA and represents Amgen,s first BLA submission ... Harper , M.D., executive vice president of Research and ...
Breaking Medicine Technology: